Halozyme Overview
Founded
1998
Status
Public
Employees
132
Stock Symbol
HALO
Share Price
$23.26
(As of Thursday Closing)
Halozyme General Information
Description
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Contact Information
Website
Formerly Known As
Global Yacht Services
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Stock Exchange
NAS
Primary Office
- 11388 Sorrento Valley Road
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Halozyme Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $23.26 | $23.60 | $12.71 - $25.68 | $3.16B | 136M | 1.66M | -$0.55 |
Halozyme Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 2,465,194 | 2,423,994 | 1,896,972 | 2,774,081 |
| Revenue | 164,397 | 195,992 | 151,862 | 316,613 |
| EBITDA | (62,456) | (56,556) | (59,364) | 85,755 |
| Net Income | (80,139) | (72,240) | (80,330) | 62,971 |
| Total Assets | 492,353 | 565,874 | 440,248 | 519,945 |
| Total Debt | 389,430 | 402,587 | 126,380 | 202,351 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Halozyme Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Halozyme‘s full profile, request access.
Request a free trial
Halozyme Executive Team (33)
20 Former Executives
Halozyme Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bernadette Connaughton | Halozyme | Board Member | 000 0000 |
| Connie Matsui | Self | Chairman & Board Member | 000 0000 |
| Helen Torley | Halozyme | President, Chief Executive Officer & Board Member | 000 0000 |
| James Daly | Self | Board Member | 000 0000 |
| Jean-Pierre Bizzari MD | Self | Board Member | 000 0000 |
5 Former Board Members